APA (7th ed.) Citation

Hoffmann, P., Krisam, J., Stremmel, W., & Gauss, A. (2019). Real-world outcomes of vedolizumab therapy in ulcerative colitis and Crohn’s disease at a tertiary referral center. Digestive diseases, 37(1), . https://doi.org/10.1159/000492322

Chicago Style (17th ed.) Citation

Hoffmann, Peter, Johannes Krisam, Wolfgang Stremmel, and Annika Gauss. "Real-world Outcomes of Vedolizumab Therapy in Ulcerative Colitis and Crohn’s Disease at a Tertiary Referral Center." Digestive Diseases 37, no. 1 (2019). https://doi.org/10.1159/000492322.

MLA (9th ed.) Citation

Hoffmann, Peter, et al. "Real-world Outcomes of Vedolizumab Therapy in Ulcerative Colitis and Crohn’s Disease at a Tertiary Referral Center." Digestive Diseases, vol. 37, no. 1, 2019, https://doi.org/10.1159/000492322.